Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Apr;87(4):1467-9.
doi: 10.1172/JCI115154.

Reversal of daunorubicin resistance in P388/ADR cells by itraconazole

S Gupta  1 , J Kim, S Gollapudi
Affiliations

Reversal of daunorubicin resistance in P388/ADR cells by itraconazole

S Gupta et al. J Clin Invest. 1991 Apr.

Abstract

Itraconazole is a recently developed triazole antifungal agent that inhibits cell membrane sterol biosynthesis. Itraconazole, in a dose-dependent manner, enhanced intracellular accumulation of daunorubicin and reversed the drug resistance in murine leukemia P388/ADR cells. In addition, itraconazole corrected the altered plasma membrane potentials of P388/ADR cells. The concentrations of itraconazole that reversed drug resistance are comparable to the plasma levels achieved by therapeutic dosage used in the treatment of fungal infections. Therefore, itraconazole is a potential candidate for in vivo use to reverse multidrug resistance in cancer with added benefit of its antifungal property.

PubMed Disclaimer

References

    1. Cancer Chemother Pharmacol. 1988;22(2):163-8 - PubMed
    1. Lancet. 1982 Nov 27;2(8309):1217 - PubMed
    1. Antimicrob Agents Chemother. 1988 Nov;32(11):1619-23 - PubMed
    1. FASEB J. 1989 Dec;3(14):2583-92 - PubMed
    1. Ann N Y Acad Sci. 1988;544:451-70 - PubMed